Brian T. Powl, Chief Commercial Officer at Kura Oncology, Inc. (KURA), sold 32,450 shares at $10.50 ($345K) on 2026-09-28, disclosed to the SEC on 2026-09-29.
Scheduled sale ($345k) by Chief Commercial Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $10.50 | 9,020 | $95K | 27.4% |
| 2 | $10.56 | 8,000 | $84K | 24.5% |
| 3 | $10.75 | 15,430 | $166K | 48.1% |
| Total | $10.63 avg | 32,450 | $345K | 100% |
| Filing → |
| KURA | SELL | 2026-05-20 | $3K | — | Filing → |
| KURA | SELL | 2026-01-27 | $54K | — | Filing → |
| KURA | SELL | 2025-11-14 | $199K | — | Filing → |